New Key Statistics Module, Z-Score and F-Score
NAS:XLO Key Ratios
Market Cap $ M | 39.66 |
Enterprise Value $ M | -26.61 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.17 |
Price/Sales | 21.74 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2.00 |
EPS (TTM) $ | -2.11 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.41 |
EV-to-EBITDA | 0.42 |
PEG | -- |
Shares Outstanding M | 43.95 |
Net Margin (%) | -2,780.27 |
Operating Margin % | -2,830.04 |
Pre-tax Margin (%) | -2,780.27 |
Quick Ratio | 2.02 |
Current Ratio | 2.02 |
ROA % (ttm) | -81.18 |
ROE % (ttm) | -151.77 |
ROIC % (ttm) | -241.44 |
Dividend Yield % | -- |
Altman Z-Score | -6.99 |
XLO Number of Guru Trades
XLO Volume of Guru Trades
Gurus Latest Trades with NAS:XLO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:XLO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Xilio Therapeutics Inc Insider Transactions
No Available Data
News about NAS:XLO
Total 0- 1